Price T Rowe Associates Inc Care Dx, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 24,100 shares of CDNA stock, worth $600,331. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,100

Previous 30,131 20.02%

Holding current value

$600,331

Previous $468,000 60.9%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$14.41 - $33.99 $86,906 - $204,993	-6,031 Reduced 20.02%	24,100 $753,000
Q2 2024 Aug 14, 2024	BUY	$7.56 - $16.15 $5,556 - $11,870	735 Added 2.5%	30,131 $468,000
Q1 2024 May 15, 2024	BUY	$7.96 - $12.37 $18,658 - $28,995	2,344 Added 8.66%	29,396 $312,000
Q4 2023 Feb 14, 2024	SELL	$4.9 - $12.86 $78,091 - $204,949	-15,937 Reduced 37.07%	27,052 $325,000
Q3 2023 Nov 14, 2023	BUY	$7.0 - $11.26 $47,873 - $77,007	6,839 Added 18.92%	42,989 $301,000
Q2 2023 Aug 14, 2023	BUY	$7.61 - $9.46 $35,310 - $43,894	4,640 Added 14.73%	36,150 $308,000
Q1 2023 May 15, 2023	SELL	$8.83 - $17.61 $2.09 Million - $4.16 Million	-236,291 Reduced 88.23%	31,510 $289,000
Q4 2022 Feb 14, 2023	SELL	$10.88 - $20.05 $1.52 Million - $2.81 Million	-139,962 Reduced 34.32%	267,801 $3.06 Million
Q3 2022 Nov 14, 2022	SELL	$16.06 - $26.39 $10,952 - $17,997	-682 Reduced 0.17%	407,763 $6.94 Million
Q2 2022 Aug 15, 2022	SELL	$20.49 - $39.72 $6.63 Million - $12.9 Million	-323,737 Reduced 44.22%	408,445 $8.77 Million
Q1 2022 May 16, 2022	SELL	$28.19 - $46.6 $3.29 Million - $5.44 Million	-116,631 Reduced 13.74%	732,182 $27.1 Million
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $3.19 Million - $5.7 Million	77,404 Added 10.03%	848,813 $38.6 Million
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $498,516 - $775,291	-8,428 Reduced 1.08%	771,409 $48.9 Million
Q2 2021 Aug 16, 2021	SELL	$63.02 - $95.11 $1.45 Million - $2.19 Million	-22,989 Reduced 2.86%	779,837 $71.4 Million
Q1 2021 May 17, 2021	SELL	$57.62 - $95.6 $35.5 Million - $58.8 Million	-615,515 Reduced 43.4%	802,826 $54.7 Million
Q4 2020 Feb 16, 2021	BUY	$41.43 - $77.09 $58.8 Million - $109 Million	1,418,341 New	1,418,341 $103 Million

Others Institutions Holding CDNA

# of Institutions

219

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.33B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Care Dx, Inc. Transaction History